Crispr Surges After Winning The First CRISPR Gene-Editing Approval
In a world first, regulators in the U.K. approved Crispr Therapeutics' (CRSP) gene-editing treatment for two blood diseases on Thursday. CRSP stock surged on the news. The drug formerly known as exa-cel will sell under the brand name Casgevy following the approval. The Medicines and Healthcare…
#crisprtherapeutics #healthcare #regulatoryagency #greatbritain #crispr #crsp #mhra #fda #leerinkpartners #maniforoohar